NV MedTech
PrivateLast Round
Early Stage
VC
Jun 8, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NV MedTech is a medical device company that develops neurovascular treatments for brain aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NV MedTech Comparables
Compare NV MedTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ThruFlo Endovascular | 90% | |
| NeuroMedica, Inc. | 88% | |
| Wallaby Medical | 82% |
NV MedTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jun 8, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2026
Raised $21M in an early stage VC round.
NV MedTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NV MedTech's valuation, stock price, and market status.
Is NV MedTech a public or private company?
NV MedTech is a private company.
What is the current stock price of NV MedTech?
NV MedTech is a private company with no public stock price. No recent secondary market data is available.
How much is NV MedTech worth (valuation)?
Valuation information for NV MedTech is not publicly available.
Can I buy NV MedTech stock?
NV MedTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NV MedTech's last funding round?
NV MedTech's most recent funding round was Early Stage VC on June 8, 2026.
Who are the main investors in NV MedTech?
Investor information for NV MedTech is not publicly disclosed.
Will NV MedTech IPO soon?
No public IPO plans have been announced for NV MedTech.
How can I track NV MedTech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NV MedTech's secondary market activity and sign up for updates.